Cancer drug development and therapeutics

This subclass comprises research and experimental development in cancer drug development and therapeutics.

Parent Category

A

Aparicio, Samuel

Department of Pathology & Laboratory Medicine, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer drug development and therapeutics; Biomechanical engineering; Cancer Genomics; drug discovery; Computational Biology; single cell genomics

J

Jiang, Xiaoyan

Department of Medical Genetics, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer drug development and therapeutics; Studying inherited human disorders to understand human development, behaviour, physiology and degeneration, Emphasis on neurological, neuromuscular, and psychiatric diseases

L

Lallous, Nada

Department of Urologic Sciences, Faculty of Medicine

Faculty (G+PS eligible/member)

Biochemistry; Biophysics; Cancer biology; Therapeutics; Protein research; Drug resistance; transcription factors; Biochemistry, Biophysics, Cancer Biology, Therapeutics, Protein research, Drug resistance, Transcription factors

Lau, Joseph

Department of Radiology, Faculty of Medicine

Faculty (G+PS eligible/member)

Nuclear medicine; Cancer; Radiopharmaceuticals; Imaging; Radiotherapy; nuclear medicine, cancer, radiopharmaceuticals, imaging, radiotherapy

Lockwood, William

Department of Pathology & Laboratory Medicine, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer progression and metastasis; Cancer drug development and therapeutics; Mechanisms of carcinogenesis; Cancer; drug discovery; Genetics; genomics; Immune response; Lung cancer; Oncogene signaling; Proteomics; Mouse models

M

Minchinton, Andrew

Faculty of Medicine

Faculty (non-G+PS member)

Cancer progression and metastasis; Cancer drug development and therapeutics; Mechanisms of carcinogenesis; Cancer; drug discovery; Genetics; genomics; Immune response; Proteomics; Mouse models; , Cancer, Drug discovery, Genetics, Genomics, Immune response, Proteomics, Mouse models

S

Segat, Gabriela

Faculty of Medicine

Postdoctoral Fellow

Mechanisms of carcinogenesis; Cancer drug development and therapeutics; Basic pharmacology; Applied immunology (including antibody engineering, xenotransplantation and t-cell therapies); Hematology; oncology; Inflammation; Epigenetics

V

Velenosi, Thomas

Faculty of Pharmaceutical Sciences

Faculty (G+PS eligible/member)

Pharmacology and pharmaceutical sciences, n.e.c.; Cancer drug development and therapeutics; Cancer molecular targets; Metabolomics; Lipid biology (including lipidomics); Pharmacometabolomics; Pharmacology; Metabolomics; Lipidomics; mass spectrometry; Cancer; Stable isotope tracing; Bioinformatics; Pharmacometabolomics, Pharmacology, Metabolomics, Lipidomics, Mass spectrometry, Cancer, Stable isotope tracing, Bioinformatics

Picture of Banijamali, Razieh Sadat

Razieh Sadat Banijamali

Student

Doctor of Philosophy in Pathology and Laboratory Medicine (PhD)

Enhancing Triple-Negative Breast Cancer Therapeutics with Oncolytic Virotherapy
Woman wearing black jacket standing in front of blurry tree background

Xue Qi (Amy) Wang

Student

Doctor of Medicine and Doctor of Philosophy (MDPhD)

Advancing Beyond Doxorubicin: A Comprehensive Drug Screening Approach to Improve Synovial Sarcoma Treatment.
Picture of Ramos, Louise

Louise Ramos

Student

Doctor of Philosophy in Experimental Medicine (PhD)

Characterization of a novel bifunctional PARP-HDAC inhibitor in a 3-D printed human-mimetic bone model
Picture of Zhang, Yao

Yao Zhang

Student

Doctor of Philosophy in Biomedical Engineering (PhD)

Development of lipid nanoparticle formulations for small molecule and gene delivery
Picture of Friesen, Emma

Emma Friesen

Student

Master of Science in Interdisciplinary Oncology (MSc)

Targeting the Tumor Microenvironment with Radiopharmaceutical Therapy

Person in a dark shirt standing near a light wall

Vanessa Chan

Student

Doctor of Philosophy in Pharmaceutical Sciences (PhD)

Targeted Delivery of TLR7/8 Agonists for the Enhancement of Cancer Immunotherapy

French Name

Thérapeutique et mise au point de médicaments contre le cancer

French Description

Cette sous-classe comprend la recherche et le développement expérimental en thérapeutique et mise au point de médicaments contre le cancer.